Dr. Angela V. Hafner is a Patent specialist in the Patents group. Angela focuses her practice on strategic counseling and worldwide intellectual property protection for biomedical sciences and biotechnology clients.
Angela was previously a postdoctoral fellow in the laboratory of Nobel Laureate Dr. H. Robert Horvitz at the Massachusetts Institute of Technology, where she received a Leopoldina Postdoctoral Fellowship Award for her research on the biological pathways through which cells adapt to metabolic alterations. Angela graduated summa cum laude with a Ph.D. in Biochemistry from Freie University of Berlin, Germany, under the direction of Dr. David A. Sinclair at Harvard Medical School. Angela also gained international research experience in the field of neuroscience at the University College, London, U.K. and the University of Otago, New Zealand. Angela has co-authored scientific articles in the fields of biochemistry, molecular biology and neuroscience; presented her work at major biomedical conferences; and is an inventor on an issued patent. Angela is a member of the Genetics Society of America and the German Society for Biochemistry and Molecular Biology. Angela is also fluent in German.
I am using my scientific knowledge to help clients obtain worldwide protection for their biomedical inventions. In particular, my work focuses on strategic counseling, patent procurement and patent prosecution for innovative technologies in the biomedical sciences and biotechnology industry as well as on the strategic management of clients’ patent portfolios.
Life sciences and biotechnology are widely regarded as one of the most promising frontier technologies for the coming decades because of the strong health implications. Universities present an important source of new molecular targets and technologies for development and commercialization by biotechnology companies. However, there is the need for a significant amount of investment to sustain the experimentation costs. I foresee universities placing a greater emphasis on their intellectual property protection in an increasingly competitive and global marketplace.